160 related articles for article (PubMed ID: 16009575)
1. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
Wilson WR; Evans J; Bell PR; Thompson MM
Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):259-62. PubMed ID: 16009575
[TBL] [Abstract][Full Text] [Related]
2. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms.
Abisi S; Burnand KG; Humphries J; Waltham M; Taylor P; Smith A
Br J Surg; 2008 Mar; 95(3):333-7. PubMed ID: 17968978
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture.
Wilson WR; Anderton M; Schwalbe EC; Jones JL; Furness PN; Bell PR; Thompson MM
Circulation; 2006 Jan; 113(3):438-45. PubMed ID: 16432074
[TBL] [Abstract][Full Text] [Related]
4. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.
Hurks R; Hoefer IE; Vink A; Pasterkamp G; Schoneveld A; Kerver M; de Vries JP; Tangelder MJ; Moll FL
Eur J Vasc Endovasc Surg; 2010 May; 39(5):569-76. PubMed ID: 20226696
[TBL] [Abstract][Full Text] [Related]
5. Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.
Mateos-Cáceres PJ; López-Farré AJ; Morata PC; Ramos-Mozo P; Macaya C; Serrano FJ; Moñux G
Can J Physiol Pharmacol; 2008 Jul; 86(7):431-7. PubMed ID: 18641692
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Wilson WR; Schwalbe EC; Jones JL; Bell PR; Thompson MM
Br J Surg; 2005 Jul; 92(7):828-33. PubMed ID: 15918165
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
[TBL] [Abstract][Full Text] [Related]
8. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
[TBL] [Abstract][Full Text] [Related]
9. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.
Nagashima H; Aoka Y; Sakomura Y; Sakuta A; Aomi S; Ishizuka N; Hagiwara N; Kawana M; Kasanuki H
J Vasc Surg; 2002 Jul; 36(1):158-63. PubMed ID: 12096274
[TBL] [Abstract][Full Text] [Related]
10. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
11. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.
Mastoraki ST; Toumpoulis IK; Anagnostopoulos CE; Tiniakos D; Papalois A; Chamogeorgakis TP; Angouras DC; Rokkas CK
Ann Vasc Surg; 2012 Feb; 26(2):250-8. PubMed ID: 22222170
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
Wilton E; Bland M; Thompson M; Jahangiri M
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms.
Schweitzer M; Mitmaker B; Obrand D; Sheiner N; Abraham C; Dostanic S; Meilleur M; Sugahara T; Chalifour LE
Vasc Endovascular Surg; 2010 Feb; 44(2):116-22. PubMed ID: 20034937
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma MMP1 and MMP9 are associated with abdominal aortic aneurysm rupture.
Wilson WR; Anderton M; Choke EC; Dawson J; Loftus IM; Thompson MM
Eur J Vasc Endovasc Surg; 2008 May; 35(5):580-4. PubMed ID: 18226564
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue.
Yoshimura K; Nagasawa A; Kudo J; Onoda M; Morikage N; Furutani A; Aoki H; Hamano K
Int J Mol Sci; 2015 May; 16(5):11213-28. PubMed ID: 25993292
[TBL] [Abstract][Full Text] [Related]
16. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms (Br J Surg 2008; 95: 333-337).
Fujita T
Br J Surg; 2008 May; 95(5):667; author reply 667-8. PubMed ID: 18386776
[No Abstract] [Full Text] [Related]
17. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity.
Ailawadi G; Knipp BS; Lu G; Roelofs KJ; Ford JW; Hannawa KK; Bishop K; Thanaporn P; Henke PK; Stanley JC; Upchurch GR
J Vasc Surg; 2003 May; 37(5):1059-66. PubMed ID: 12756355
[TBL] [Abstract][Full Text] [Related]
18. Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.
Jguirim-Souissi I; Jelassi A; Addad F; Hassine M; Najah M; Ben Hamda K; Maatouk F; Ben Farhat M; Bouslema A; Rouis M; Slimane MN
Am J Cardiol; 2007 Jul; 100(1):23-7. PubMed ID: 17599435
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.
Evans J; Powell JT; Schwalbe E; Loftus IM; Thompson MM
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):302-3. PubMed ID: 17574455
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP; Liapis CD
Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
